Overview

First Time in Human Study With GSK1325756

Status:
Completed
Trial end date:
2010-03-02
Target enrollment:
Participant gender:
Summary
This study aims to investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of single, oral ascending doses, and repeat oral doses of GSK1325756 administered to healthy adult male volunteers. This study is the First Time in Human study for GSK1325756.
Phase:
Phase 1
Details
Lead Sponsor:
GlaxoSmithKline